{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:11:25Z","timestamp":1776777085267,"version":"3.51.2"},"reference-count":27,"publisher":"Siapec Servizi Srl","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-955","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T08:53:37Z","timestamp":1720515217000},"page":"163-169","source":"Crossref","is-referenced-by-count":7,"title":["SMARCB1\/INI1-deficient undifferentiated tumour of the thorax: a case report and review of the literature"],"prefix":"10.32074","volume":"116","author":[{"given":"Moreno","family":"Zagni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Marando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariachiara","family":"Negrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calogero","family":"Lauricella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Paglino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Valtorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Bonoldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21774","published-online":{"date-parts":[[2024,6]]},"reference":[{"key":"10.32074\/1591-951X-955_ref1","doi-asserted-by":"crossref","unstructured":"Kohashi K, Oda Y. Oncogenic roles of SMARCB1\/INI1 and its deficient tumors. Cancer Sci. 2017;108(4):547-552. https:\/\/doi.org\/10.1111\/cas.13173. Epub 2017 Apr 12. PMID: 28109176; PMCID: PMC5406539.","DOI":"10.1111\/cas.13173"},{"key":"10.32074\/1591-951X-955_ref2","unstructured":"Board WC. Thoracic Tumours: WHO Classification of Tumours. World Health organ classif tumours. 5th ed. Lyon France: International Agency for Research on Cancer 2021."},{"key":"10.32074\/1591-951X-955_ref3","doi-asserted-by":"crossref","unstructured":"Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J Thorac Oncol. 2022;17(3):362-387. https:\/\/doi.org\/10.1016\/j.jtho.2021.11.003. Epub 2021 Nov 20. PMID: 34808341.","DOI":"10.1016\/j.jtho.2021.11.003"},{"key":"10.32074\/1591-951X-955_ref4","doi-asserted-by":"crossref","unstructured":"Nambirajan A, Jain D. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor. Semin Diagn Pathol. 2021;38(5):83-89. https:\/\/doi.org\/10.1053\/j.semdp.2021.06.001. Epub 2021 Jun 4. PMID: 34147303.","DOI":"10.1053\/j.semdp.2021.06.001"},{"key":"10.32074\/1591-951X-955_ref5","doi-asserted-by":"crossref","unstructured":"Parker NA, Al-Obaidi A, Deutsch JM. SMARCB1\/INI1-deficient tumors of adulthood. F1000Res. 2020;30(9):662. https:\/\/doi.org\/10.12688\/f1000research.24808.2. PMID: 33796273; PMCID: PMC7968524.","DOI":"10.12688\/f1000research.24808.2"},{"key":"10.32074\/1591-951X-955_ref6","doi-asserted-by":"crossref","unstructured":"Del Savio E, Maestro R. Beyond SMARCB1 Loss: Recent Insights into the Pathobiology of Epithelioid Sarcoma. Cells. 2022;11(17):2626. https:\/\/doi.org\/10.3390\/cells11172626. PMID: 36078034; PMCID: PMC9454995.","DOI":"10.3390\/cells11172626"},{"key":"10.32074\/1591-951X-955_ref7","doi-asserted-by":"crossref","unstructured":"Cooper GW, Hong AL. SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities. Cancers. 2022;14(15):3645. https:\/\/doi.org\/10.3390\/cancers14153645. PMID: 35892904; PMCID: PMC9332782","DOI":"10.3390\/cancers14153645"},{"key":"10.32074\/1591-951X-955_ref8","doi-asserted-by":"crossref","unstructured":"Agaimy A, Hartmann A. SMARCB1(INI1)-deficient renal cell carcinoma: medullary and beyond: evolving concepts. Pathologe. 2021;42(6):571-577.","DOI":"10.1007\/s00292-021-00985-y"},{"key":"10.32074\/1591-951X-955_ref9","doi-asserted-by":"crossref","unstructured":"Agaimy A, Hartmann A, Antonescu CR, et al. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity. Am J Surg Pathol. 2017;41(4):458-471.","DOI":"10.1097\/PAS.0000000000000797"},{"key":"10.32074\/1591-951X-955_ref10","doi-asserted-by":"crossref","unstructured":"Pawel BR. SMARCB1-deficient Tumors of Childhood: A Practical Guide. Pediatr Dev Pathol. 2018;21(1):6-28. https:\/\/doi.org\/10.1177\/1093526617749671. Epub 2017 Dec 27. PMID: 29280680.","DOI":"10.1177\/1093526617749671"},{"key":"10.32074\/1591-951X-955_ref11","doi-asserted-by":"crossref","unstructured":"Mobley BC, McKenney JK, Bangs CD, et al. Loss of SMARCB1\/INI1 expression in poorly differentiated chordomas. Acta Neuropathol. 2010;120(6):745-53.","DOI":"10.1007\/s00401-010-0767-x"},{"key":"10.32074\/1591-951X-955_ref12","doi-asserted-by":"crossref","unstructured":"Yoshida M, Yamashita D, Hamakawa H, et al. SMARCB1-deficient myoepithelial carcinoma of the lung: A case report. Hum Pathol Case Rep 2020;21:200414. https:\/\/doi.org\/10.1016\/j.ehpc.2020.200414.","DOI":"10.1016\/j.ehpc.2020.200414"},{"key":"10.32074\/1591-951X-955_ref13","doi-asserted-by":"crossref","unstructured":"Agaimy A, Rau TT, Hartmann A, et al. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. Am J Surg Pathol. 2014;38(7):910-20. https:\/\/doi.org\/10.1097\/PAS.0000000000000173. PMID: 24503755.","DOI":"10.1097\/PAS.0000000000000173"},{"key":"10.32074\/1591-951X-955_ref14","doi-asserted-by":"crossref","unstructured":"Agaimy A, Haller F, Frohnauer J, et al. Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes. Mod Pathol. 2015;28(2):248-60. https:\/\/doi.org\/10.1038\/modpathol.2014.100. Epub 2014 Aug 8. PMID: 25103069.","DOI":"10.1038\/modpathol.2014.100"},{"key":"10.32074\/1591-951X-955_ref15","doi-asserted-by":"crossref","unstructured":"Hua Y, Soni P, Larsen D, et al. SMARCB1\/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature. World J Gastroenterol. 2020;26(36):5520-5526. https:\/\/doi.org\/10.3748\/wjg.v26.i36.5520. PMID: 33024402; PMCID: PMC7520612.","DOI":"10.3748\/wjg.v26.i36.5520"},{"key":"10.32074\/1591-951X-955_ref16","doi-asserted-by":"crossref","unstructured":"Gupta S, Albertson D, Gaston D, et al. Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System. Clin Genitourin Cancer. 2018;16(2):e373-e382. https:\/\/doi.org\/10.1016\/j.clgc.2017.09.001. Epub 2017 Sep 7. PMID: 28974397.","DOI":"10.1016\/j.clgc.2017.09.001"},{"key":"10.32074\/1591-951X-955_ref17","doi-asserted-by":"crossref","unstructured":"Kang EY, Tessier-Cloutier B, Duggan MA, et al. Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated\/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix. Histopathology. 2021;79(2):160-167. https:\/\/doi.org\/10.1111\/his.14333. Epub 2021 Jun 2. PMID: 33432679.","DOI":"10.1111\/his.14333"},{"key":"10.32074\/1591-951X-955_ref18","unstructured":"AACR Project Genie Consortium AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 2017;7:818-831."},{"key":"10.32074\/1591-951X-955_ref19","doi-asserted-by":"crossref","unstructured":"Wang N, Qin Y, Du F, et al. Prevalence of SWI\/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: A systematic review and meta-analysis. Gene. 2022;834:146638.","DOI":"10.1016\/j.gene.2022.146638"},{"key":"10.32074\/1591-951X-955_ref20","doi-asserted-by":"crossref","unstructured":"Merker VL, Esparza S, Smith MJ, et al. Clinical features of schwannomatosis: A retrospective analysis of 87 patients. Oncologist. 2012;17:1317-1322.","DOI":"10.1634\/theoncologist.2012-0162"},{"key":"10.32074\/1591-951X-955_ref21","doi-asserted-by":"crossref","unstructured":"Hulsebos TJ, Plomp AS, Wolterman RA, et al. Germline mutation of INI1\/SMARCB1 in familial schwannomatosis. Am J Hum Genet. 2007;80(4):805-10. https:\/\/doi.org\/10.1086\/513207. Epub 2007 Feb 16. PMID: 17357086; PMCID: PMC1852715.","DOI":"10.1086\/513207"},{"key":"10.32074\/1591-951X-955_ref22","doi-asserted-by":"crossref","unstructured":"Smith MJ, Wallace AJ, Bowers NL, et al. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. Cancer Genet. 2014;207(9):373-8. https:\/\/doi.org\/10.1016\/j.cancergen.2014.04.001. Epub 2014 Apr 8. PMID: 24933152.","DOI":"10.1016\/j.cancergen.2014.04.001"},{"key":"10.32074\/1591-951X-955_ref23","doi-asserted-by":"crossref","unstructured":"Yoshida K, Fujiwara Y, Goto Y, et al. The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report. BMC Cancer. 2018;18(1):398. Published 2018 Apr 7. doi:10.1186\/s12885-018-4321-x","DOI":"10.1186\/s12885-018-4321-x"},{"key":"10.32074\/1591-951X-955_ref24","doi-asserted-by":"crossref","unstructured":"Haberecker M, B\u00fchler MM, Mendieta AP, et al. Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms. Mod Pathol. 2022;35(12):1860-1869. https:\/\/doi.org\/10.1038\/s41379-022-01133-4.","DOI":"10.1038\/s41379-022-01133-4"},{"key":"10.32074\/1591-951X-955_ref25","unstructured":"Zhou YH, Qin S, Yan JX, et al. INI1 (SMARCB1) deletion of lung cancer: report of a case. Zhonghua Bing Li Xue Za Zhi. 2022 51:902-4. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20220207-00076"},{"key":"10.32074\/1591-951X-955_ref26","doi-asserted-by":"crossref","unstructured":"Rickard JA, Burr ML, Williams B, et al. SMARCB1\/INI1-deficient primary lung carcinoma with hepatic metastasis. Pathology. 2022;54(6):817-820. https:\/\/doi.org\/10.1016\/j.pathol.2021.11.010.","DOI":"10.1016\/j.pathol.2021.11.010"},{"key":"10.32074\/1591-951X-955_ref27","doi-asserted-by":"crossref","unstructured":"Chen J and Wang J. STK11 loss and SMARCB1 deficiency mutation in a dedifferentiated lung cancer patient present response to neo-adjuvant treatment with pembrolizumab and platinum doublet: A case report. Front Oncol. 2023;13:1088534. https:\/\/doi.org\/10.3389\/fonc.2023.1088534","DOI":"10.3389\/fonc.2023.1088534"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:27:59Z","timestamp":1730813279000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.pathologica.it\/article\/view\/955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-955","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"article-number":"5"}}